[1] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
[2] |
Pan Meimin, Li Wenjuan, Zhang Xuehong, Yang Lihui, He Juan, Tan Yongwei.
Study on serum TNFSF14 and sIL-2R levels in elderly patients with pulmonary tuberculosis and their correlation with short-term prognosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 66-71.
|
[3] |
Gao Lei, Liang Yaxue, Liu Shengsheng, Wang Hua.
Analysis of treatment outcomes and influencing factors in 144 elderly patients with rifampicin drug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 799-807.
|
[4] |
Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong.
Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698.
|
[5] |
Yang Chao, Wang Jing, Yang Chaohui, Gao Hanqing.
Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis aged ≥60 years old in Tongzhou District of Beijing, 2016—2022
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 403-410.
|
[6] |
Xu Henan, Lai Congjuan, Zhang Zunjing, Guo Jing, Xu Lixia, Zhang Ying, Liu Zhongda.
Analysis of drug resistance in clinical isolates from 610 elderly tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1490-1495.
|
[7] |
Kong Hanhan, Zhang Jiaohong, Zeng Jianfeng, Cao Jing.
Construction and validation of frailty risk prediction model in elderly patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 85-91.
|
[8] |
Teng Rencong, Li Tao, LI Yuhong, Yang Chenlu, Zhang Canyou, Zhao Yanlin, Zhang Hui.
Analysis of registration records of elderly pulmonary tuberculosis patients aged 65 and above in China,2015—2021
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 367-371.
|
[9] |
Zhu Ping, Hao Xiaogang, Wang Wei, Chen Bin.
Epidemiological characteristics of inactive pulmonary tuberculosis among the elderly in high-endemic rural areas in Quzhou City, Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2022, 44(8): 815-820.
|
[10] |
QIN Li-yi, LYU Yan, YANG Yang, JIA Jun-nan, HUO Feng-min, LI Wei-min, LYU Ping-xin.
CT features of residual inactive tuberculosis lesions in cured patients of pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 336-342.
|
[11] |
CHEN Ke-fan, XIONG Yu-jiao, JIAO Jia-huan, YUAN Shu-sheng.
Value of CD44 and related cytokine levels in the diagnosis and prognosis evaluation of active pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(5): 513-515.
|
[12] |
Tuberculosis Branch of Chinese Medical Association .
Expert advice on anti-novel coronavirus vaccination for tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1239-1242.
|
[13] |
SHEN Xin, SHA Wei, LIU Jian-jun.
Impact of coronavirus disease 2019 (COVID-19) on tuberculosis control and countermeasures in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 544-548.
|
[14] |
CHEN Juan, MAO Yi, CHEN Hong-de.
The clinical features and prognostic analysis of 30 pregnant or parturient women with severe tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 638-640.
|
[15] |
The Group of Osteoarticular Tuberculosis.
Guidelines on surgical treatment of osteoarticular tuberculosis in facing novel coronavirus pneumonia
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 185-190.
|